| Primary |
| Drug Use For Unknown Indication |
27.9% |
| Product Used For Unknown Indication |
25.8% |
| Rhinitis Allergic |
8.5% |
| Hypersensitivity |
6.8% |
| Urticaria |
5.1% |
| Seasonal Allergy |
4.0% |
| Asthma |
3.7% |
| Nasopharyngitis |
2.7% |
| Pruritus |
2.0% |
| Rhinitis |
1.9% |
| Hypertension |
1.4% |
| Pyrexia |
1.4% |
| Depression |
1.3% |
| Multiple Allergies |
1.3% |
| Premedication |
1.3% |
| Cough |
1.2% |
| Rash |
1.1% |
| Sinusitis |
0.9% |
| Suicide Attempt |
0.9% |
| Prophylaxis |
0.8% |
|
| Vomiting |
10.7% |
| Urticaria |
8.8% |
| Tachycardia |
7.5% |
| Cytolytic Hepatitis |
6.3% |
| Somnolence |
6.3% |
| Angioedema |
5.7% |
| Dyspnoea |
5.0% |
| Hallucination |
5.0% |
| Condition Aggravated |
4.4% |
| Hallucination, Visual |
4.4% |
| Syncope |
4.4% |
| Epilepsy |
3.8% |
| Loss Of Consciousness |
3.8% |
| Speech Disorder |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Vertigo |
3.8% |
| Delusion |
3.1% |
| Dizziness |
3.1% |
| Drug Ineffective |
3.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
28.4% |
| Asthma |
18.6% |
| Drug Use For Unknown Indication |
8.1% |
| Urticaria |
6.9% |
| Epilepsy |
4.9% |
| Premedication |
4.2% |
| Hypertension |
3.6% |
| Rhinitis |
3.3% |
| Thrombosis Prophylaxis |
2.5% |
| Prophylaxis |
2.4% |
| Osteoporosis |
2.2% |
| Hypersensitivity |
2.0% |
| Pneumonia Legionella |
2.0% |
| Rhinitis Allergic |
2.0% |
| Breast Cancer |
1.6% |
| Cough |
1.6% |
| Nasopharyngitis |
1.6% |
| Pain |
1.4% |
| Sinusitis |
1.4% |
| Depression |
1.3% |
|
| Deep Vein Thrombosis |
14.4% |
| Urticaria |
9.3% |
| Tachycardia |
7.2% |
| Thrombocytopenia |
7.2% |
| Toxic Skin Eruption |
6.2% |
| Myocardial Infarction |
5.2% |
| Squamous Cell Carcinoma |
5.2% |
| Vomiting |
5.2% |
| Confusional State |
4.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.1% |
| Electrocardiogram Qt Prolonged |
4.1% |
| Blood Pressure Increased |
3.1% |
| Cytolytic Hepatitis |
3.1% |
| Drug Ineffective |
3.1% |
| Photosensitivity Reaction |
3.1% |
| Psychiatric Decompensation |
3.1% |
| Rhinitis |
3.1% |
| Somnolence |
3.1% |
| Suicide Attempt |
3.1% |
| Urticaria Chronic |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.9% |
| Drug Use For Unknown Indication |
11.6% |
| Asthma |
8.0% |
| Hypertension |
5.2% |
| Pain |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Premedication |
2.9% |
| Crohn's Disease |
2.8% |
| Hypersensitivity |
2.6% |
| Prophylaxis |
2.6% |
| Hepatitis C |
2.4% |
| Depression |
2.4% |
| Hiv Infection |
2.2% |
| Diabetes Mellitus |
1.4% |
| Osteoporosis |
1.3% |
| Rhinitis Allergic |
1.3% |
| Atrial Fibrillation |
1.2% |
| Angina Pectoris |
1.1% |
| Unevaluable Event |
1.1% |
| Seasonal Allergy |
1.0% |
|
| Vomiting |
12.4% |
| Weight Increased |
7.7% |
| Neutropenia |
7.2% |
| Renal Failure Acute |
6.7% |
| Toxic Skin Eruption |
6.7% |
| Rash |
5.7% |
| Urticaria |
5.7% |
| Hyponatraemia |
4.1% |
| Swelling Face |
4.1% |
| Asthenia |
3.6% |
| Breast Cancer |
3.6% |
| Death |
3.6% |
| Drug Interaction |
3.6% |
| Malaise |
3.6% |
| Nausea |
3.6% |
| Rhinitis Allergic |
3.6% |
| Syncope |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Tumour Lysis Syndrome |
3.6% |
| Weight Decreased |
3.6% |
|
